The Competition Authority recommends opening notary fees to price competition
Veel uudiseid samal teemal
The Competition Authority conducted an analysis of the competition situation in order to assess the functioning of the regulation that sets the limits for the prices of medicines. The Competition Authority considers that the current system for the mark-up of medicines is deficient and its supervision is fragmented. As a result, there is a significant risk of non-compliance with the set rules.
Today, all competition authorities in the European Competition Network (the European Commission, the European Surveillance Authority, and the national competition authorities of the EU/EEA) are issuing a joint statement on how to apply the European competition rules during the crisis.